report cover1

Short Bowel Syndrome Market “By Drug Type: (Glucagon-Like Peptide-2(Glp2), Growth Hormone, Glutamine, Anti-Diarrheal, Proton Pump Inhibitors And Others); By Diagnosis (Physical Exam, Faecal Tests, Imaging Procedures And Others); By Treatment (Nutritional Therapy, Medications, Surgery And Transplant); By Route Of Administration (Oral, Parenteral And Others); By End-Users (Hospitals, Homecare, Specialty Clinics And Others); By Distribution Channel (Hospital Pharmacy, Online Pharmacy And Retail Pharmacy)” - Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

A prominent research firm, Cognizance Market Research added a cutting-edge industry report on “Short Bowel Syndrome Market”. The report studies the current as well as past growth trends and opportunities for the market to gain valuable insights during the forecast period from 2023 to 2030.

Short Bowel Syndrome Market Analysis

According to cognizance market research the short bowel syndrome market is expected to register CAGR of 14.7% from 2023 to 2030.

short bowel syndrome market

What is Short Bowel Syndrome?

A portion of the small and/or large intestine may become physically absent or cease to operate, resulting in the complex disease known as short bowel syndrome. As a result, those who suffer from short bowel syndrome frequently have a decreased capacity for absorbing nutrients like lipids, carbohydrates (sugars), vitamins, minerals, trace elements, and fluids. (malabsorption). Short bowel syndrome symptoms can differ from person to person, as can their severity. Common, frequently serious, and potentially fatal dehydration are all effects of diarrhoea. Malnutrition, unintended weight loss, and other signs of short bowel syndrome may be brought on by a lack of vital vitamins and minerals. Although there is no cure, the condition is typically treatable successfully.

Depending on how well the small intestine is functioning, it can be mild, moderate, or severe in individuals. Additionally, individuals with short bowel syndrome are unable to absorb enough water, protein, fat, calories, minerals, and vitamins from their diet. Birth defects, gastrointestinal injuries, and intestinal illnesses are some of the causes of short bowel syndrome.

Short bowel syndrome, however, can occasionally result in serious, incapacitating, and even fatal consequences. Most frequently, the surgical removal (resection) of half or more of the small intestine leads to short bowel syndrome. These procedures are used to deal with inherited birth defects, small bowel injuries, and congenital intestinal diseases like Crohn’s disease. The development and/or management of short bowel syndrome are both significantly influenced by the existence or absence of the large intestine (colon).

Short Bowel Syndrome Market Outlook

In the smart bowel syndrome report, the market outlook segment mainly includes important dynamics of the market which include drivers, restraints, opportunities and challenges tackled by the industry. Opportunities and challenges are extrinsic factors whereas, drivers and restraints are intrinsic factors of the market.

The rising incidence of this syndrome in countries such as the U.S., Canada, and the U.K. is increasing the need to develop innovative drug manufacturers to treat this condition. According to the data published by Crohn’s & Colitis Foundation, around 10,000 to 20,000 people have this condition in the U.S. Over the past few years, short intestine syndrome has become more common everywhere. The sector has grown more rapidly as a result of the rising number of patients receiving total parenteral nutrition.

Over the course of the forecast period, the development of the global market for short bowel syndrome medications may be restrained due to lack of qualified employees who are unable to treat patients with these medications. These types of syndromes are extremely expensive to treat, making them particularly costly for low-income groups. Lack of compensation guidelines and the restricted accessibility of authorized medications in nations like India, Africa, and others are further impeding market expansion.

Segment Analysis:

The short bowel syndrome market has been segmented into drug type, diagnosis, treatment, route of administration, end-users, distribution channel and geography.

Based on drug type the short bowel syndrome market is further segmented into glucagon-like peptide-2(GLP2), Growth hormone, glutamine, anti-diarrheal, proton pump inhibitors and others. The GLP 2 segment held a dominant share in the market. Growth hormone is anticipated to register a higher CAGR during the forecast period.

Based on diagnosis, the short bowel syndrome market is classified into physical exams, faecal tests, imaging procedures and other diagnosis. Based on treatment, the market for short bowel syndrome is further bifurcated into nutritional therapy, medications, surgery and transplant. Among the medication, Glucagon-Like Peptide-2(Glp2) accounted for about 80% share in the 2022, and expected to remain dominant over the estimated timeframe over the forecast period.

Based on route of administration, the short bowel syndrome market is further segmented into oral, parenteral and others. Based on end-users, the short bowel syndrome market is classified into hospitals, homecare, specialty clinics and others.

Based on distribution channel, the market for short bowel syndrome is bifurcated into hospital pharmacy, retail pharmacy and online pharmacy. The online and retail pharmacies segment is expected to generate the highest revenue among the distribution channel segment.

Geographical Analysis:

Based on geography the short bowel syndrome market has been segmented into five main regions namely, North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. The high prevalence of short bowel syndrome and increased research and development activity in North America have contributed to the region’s positive growth in the global market for short bowel syndrome medications over the course of the anticipated era.

A large number of generic manufacturers, expanding healthcare infrastructure, and an increase in government efforts and specialized communities all contribute to Asia-Pacific’s market dominance. During the years 2023-2030, growth in Latin America and the Middle East & Africa is anticipated to be substantial. The rise during the forecast period can be attributed to the increasing public awareness of rare diseases as well as the expanding need and demand for advanced products in these areas.

geographical analysis

The report offers the revenue of the short bowel syndrome market for the period 2020-2030, considering 2020 & 2021 as a historical year, 2022 as the base year and 2023 to 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the short bowel syndrome market for the forecast period. The short bowel syndrome market report provides insights and in-depth analysis into developments impacting enterprises and businesses on a regional and global level. The report covers the short bowel syndrome market performance in terms of revenue contribution from several segments and comprises a detailed analysis of key drivers, trends, restraints, and opportunities prompting revenue growth of the short bowel syndrome market.

The report has been prepared after wide-ranging secondary and primary research. Secondary research included internet sources, numerical data from government organizations, trade associations, and websites. Analysts have also employed an amalgamation of bottom-up and top-down approaches to study numerous phenomena in the short bowel syndrome market. Secondary research involved a detailed analysis of significant players’ product portfolio. Literature review, press releases, annual reports, white paper, and relevant documents have been also studied to understand the short bowel syndrome market. Primary research involved a great extent of research efforts, wherein experts carried out interviews telephonic as well as questioner-based with industry experts and opinion-makers.

The report includes an executive summary, along with a growth pattern of different segmented included in the scope of the study. The Y-o-Y analysis with elaborate market insights has been provided in the report to comprehend the Y-o-Y trends in the short bowel syndrome market. Additionally, the report focuses on altering competitive dynamics in the global market. These indices serve as valued tools for present market players as well as for companies interested in participating in the short bowel syndrome market. The subsequent section of the short bowel syndrome report highlights the USPs, which include key industry events (Type launch, research partnership, acquisition, etc.), technology advancements, pipeline analysis, prevalence data, and regulatory scenario.

Short Bowel Syndrome Market Competitive Landscape

There are several well-known industry companies present in the moderately competitive short bowel syndrome market. Important market players are forming alliances with one another and buying market products, while other businesses are boosting their worldwide market share. Some of the major competitors in the short bowel syndrome market are as follows:

  • 9 Meters Biopharma, Inc.
  • Alvogen
  • Amneal Pharmaceuticals LLC.
  • Boehringer Ingelheim International GmbH
  • GSK Plc.
  • Hanmi Pharm.Co., Ltd.
  • Hikma Pharmaceuticals PLC
  • Novartis AG
  • Nutrinia Ltd.
  • Pharmascience, Inc
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Johnsons & Johnsons Services Inc
  • Merck KGaA, Zealand Pharma A/S
  • OxThera
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • VectivBio AG

VectivBio Holding AG reported in June 2021 that the FDA had designated Apraglutide as an orphan medication. It is a long-acting, next-generation GLP-2 analog that is being created for the treatment of acute graft-versus-host disease and uncommon gastrointestinal disorders. (aGVHD).

Hanmi Pharm. Co. Ltd. reported in April 2021 that the U.S. FDA had given its short-bowel syndrome treatment, LAPS GLP-2 Analog, fast-track designation. (HM15912). A novel biopharmaceutical called LAPS GLP-2 Analog has been created for short bowel syndrome using the company’s platform technology, Labscovery. The disorder has a survival rate of under 50%, affects children and teenagers’ growth significantly and effects about 24.5 out of every 100,000 new-borns.

The report explores the competitive scenario of the shott bowel syndrome market. Major players operating in the short bowel syndrome market have been identified and profiled for unique commercial attributes. Company overview (company description, Type portfolio, geographic presence, employee strength, Key management, etc.), financials, SWOT analysis, recent developments, and key strategies are some of the features of companies profiled in the short bowel syndrome market report.


Short Bowel Syndrome Market, by Drug Type

  • Glucagon-Like Peptide-2 (GLP2)
  • Growth Hormone
  • Glutamine
  • Anti-Diarrheal
  • Proton Pump Inhibitors
  • Others

Short Bowel Syndrome Market, by Diagnosis

  • Physical Exam
  • Faecal Tests
  • Imaging Procedures
  • Others

Short Bowel Syndrome Market, by Treatment

  • Nutritional Therapy
  • Medications
  • Surgery
  • Transplant

Short Bowel Syndrome Market, by Route of Administration

  • Oral
  • Parenteral
  • Others

Short Bowel Syndrome Market, by End-User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Short Bowel Syndrome Market, by Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Short bowel syndrome Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia & New Zealand
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
Complete the form below and we'll get back to you shortly
Table of Content

Research Methodology: Aspects

Market research is a crucial tool for organizations aiming to navigate the dynamic landscape of customer preferences, business trends, and competitive landscapes. At Cognizance Market Research, acknowledging the importance of robust research methodologies is vital to delivering actionable insights to our clientele. The significance of such methodologies lies in their capability to offer clarity in complexity, guiding strategic management with realistic evidence rather than speculation. Our clientele seek insights that excel superficial observations, reaching deep into the details of consumer behaviours, market dynamics, and evolving opportunities. These insights serve as the basis upon which businesses craft tailored approaches, optimize product offerings, and gain a competitive edge in an ever-growing marketplace.

The frequency of information updates is a cornerstone of our commitment to providing timely, relevant, and accurate insights. Cognizance Market Research adheres to a rigorous schedule of data collection, analysis, and distribution to ensure that our reports reflect the most current market realities. This proactive approach enables our clients to stay ahead of the curve, capitalize on emerging trends, and mitigate risks associated with outdated information.

Our research process is characterized by meticulous attention to detail and methodological rigor. It begins with a comprehensive understanding of client objectives, industry dynamics, and research scope. Leveraging a combination of primary and secondary research methodologies, we gather data from diverse sources including surveys, interviews, industry reports, and proprietary databases. Rigorous data analysis techniques are then employed to derive meaningful insights, identify patterns, and uncover actionable recommendations. Throughout the process, we remain vigilant in upholding the highest standards of data integrity, ensuring that our findings are robust, reliable, and actionable.

Key phases involved in in our research process are mentioned below:


Understanding Clients’ Objectives:

Extensive Discussions and Consultations:

  • We initiate in-depth discussions and consultations with our clients to gain a comprehensive understanding of their objectives. This involves actively listening to their needs, concerns, and aspirations regarding the research project.
  • Through these interactions, we aim to uncover the underlying motivations driving their research requirements and the specific outcomes they hope to achieve.

Industry and Market Segment Analysis:

  • We invest time and effort in comprehensively understanding our clients’ industry and market segment. This involves conducting thorough research into market trends, competitive dynamics, regulatory frameworks, and emerging opportunities or threats.
  • By acquiring a deep understanding of the broader industry landscape, we can provide context-rich insights that resonate with our clients’ strategic objectives.

Target Audience Understanding:

  • We analyze our clients’ target audience demographics, behaviors, preferences, and needs to align our research efforts with their consumer-centric objectives. This entails segmenting the audience based on various criteria such as age, gender, income level, geographic location, and psychographic factors.
  • By understanding the nuances of the target audience, we can tailor our research methodologies to gather relevant data that illuminates consumer perceptions, attitudes, and purchase intent.


Identifying Challenges and Opportunities:

  • We proactively identify the challenges and opportunities facing our clients within their respective industries. This involves conducting SWOT (Strengths, Weaknesses, Opportunities, Threats) analyses and competitive benchmarking exercises.
  • By identifying potential obstacles and growth drivers, we can provide strategic recommendations that help our clients navigate complexities and capitalize on emerging opportunities effectively.

Grasping Specific Goals:

  • We delve into the intricacies of our clients’ objectives to gain clarity on the specific goals they aim to accomplish through the research. This entails understanding their desired outcomes, such as market expansion, product development, or competitive analysis.
  • By gaining a nuanced understanding of our clients’ goals, we can tailor our research approach to address their unique challenges and opportunities effectively.

Data Collection:


Primary Research Process:

  • Surveys: We design and administer surveys tailored to capture specific information relevant to our clients’ objectives. This may involve employing various survey methodologies, such as online, telephone, or face-to-face interviews, to reach target audiences effectively.
  • Interviews: We conduct structured or semi-structured interviews with key stakeholders, industry experts, or target consumers to gather in-depth insights and perspectives on relevant topics. These interviews allow us to probe deeper into specific issues and uncover valuable qualitative data.
  • Focus Groups: We organize focus group discussions with carefully selected participants to facilitate interactive discussions and gather collective opinions, attitudes, and preferences. This qualitative research method provides rich contextual insights into consumer behaviors and perceptions.
  • Observations: We conduct observational research by directly observing consumer behaviors, interactions, and experiences in real-world settings. This method enables us to gather objective data on consumer actions and reactions without relying on self-reported information.

Secondary Research Process:

  • Literature Review: We conduct comprehensive literature reviews to identify existing studies, academic articles, and industry reports relevant to the research topic. This helps us gain insights into previous research findings, theoretical frameworks, and best practices.
  • Industry Reports: We analyze industry reports published by reputable trade associations (whitepapers, research studies, etc.), and government agencies (U.S. Census Bureau, Bureau of Labor Statistics, and Securities and Exchange Commission etc.) to obtain macro-level insights into market trends, competitive landscapes, and industry dynamics.
  • Government Publications: We review government publications, such as economic reports, regulatory documents, and statistical databases, to gather relevant data on demographics, market size, consumer spending patterns, and regulatory frameworks.
  • Online Databases: We leverage online databases, such as industry portals, and academic repositories (PubMed Central (PMC), ScienceDirect, SSRN (Social Science Research Network), Directory of Open Access Journals (DOAJ), NCBI, etc.), to access a wide range of secondary data sources, including market statistics, financial data, and industry analyses.





Data Analysis:

The data analysis phase serves as a critical juncture where raw data is transformed into actionable insights that inform strategic decision-making. Through the utilization of analytical methods such as statistical analysis and qualitative techniques like thematic coding, we uncover patterns, correlations, and trends within the data. By ensuring the integrity and validity of our findings, we strive to provide clients with accurate and reliable insights that accurately reflect the realities of the market landscape.



Transformation of Raw Data:

  • Upon collecting the necessary data, we transition into the data analysis phase, where raw data is processed and transformed into actionable insights. This involves organizing, cleaning, and structuring the data to prepare it for analysis.

Utilization of Analytical Methods:

  • Depending on the research objectives, we employ a diverse range of analytical methods to extract meaningful insights from the data. These methods include statistical analysis, trend analysis, regression analysis, and qualitative coding.

Statistical Analysis:

  • Statistical tools are instrumental in uncovering patterns, correlations, and trends within the data. By applying statistical techniques such as descriptive statistics, hypothesis testing, and multivariate analysis, we can discern relationships and derive valuable insights.

Qualitative Analysis Techniques:

  • In addition to quantitative analysis, we leverage qualitative analysis techniques to gain deeper insights from qualitative data sources such as interviews or open-ended survey responses. One such technique is thematic coding, which involves systematically categorizing and interpreting themes or patterns within qualitative data.

Integrity and Validity Maintenance:

  • Throughout the analysis process, we maintain a steadfast commitment to upholding the integrity and validity of our findings. This entails rigorous adherence to established methodologies, transparency in data handling, and thorough validation of analytical outcomes.

Data Validation:

The final phase of our research methodology is data validation, which is essential for ensuring the reliability and credibility of our findings. Validation involves scrutinizing the collected data to identify any inconsistencies, errors, or biases that may have crept in during the research process. We employ various validation techniques, including cross-referencing data from multiple sources, conducting validity checks on survey instruments, and seeking feedback from independent experts or peer reviewers. Additionally, we leverage internal quality assurance protocols to verify the accuracy and integrity of our analysis. By subjecting our findings to rigorous validation procedures, we instill confidence in our clients that the insights they receive are robust, reliable, and trustworthy.


Importance of Data Validation:

  • Data validation is the final phase of the research methodology, crucial for ensuring the reliability and credibility of the findings. It involves a systematic process of reviewing and verifying the collected data to detect any inconsistencies, errors, or biases.

Scrutiny of Collected Data:

  • The validation process begins with a thorough scrutiny of the collected data to identify any discrepancies or anomalies. This entails comparing data points, checking for outliers, and verifying the accuracy of data entries against the original sources.

Validation Techniques:

  • Various validation techniques are employed to ensure the accuracy and integrity of the data. These include cross-referencing data from multiple sources to corroborate findings, conducting validity checks on survey instruments to assess the reliability of responses, and seeking feedback from independent experts or peer reviewers to validate the interpretation of results.

Internal Quality Assurance Protocols:

  • In addition to external validation measures, internal quality assurance protocols are implemented to further validate the accuracy of the analysis. This may involve conducting internal audits, peer reviews, or data validation checks to ensure that the research process adheres to established standards and guidelines.

Report Scope:



Market Size

US$ 720.28 Million (2030)

Compound Annual Growth Rate (CAGR)


Base Year


Forecast Period


Forecast Units

Value (US$ Million)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Geographies Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Countries Covered

U.S., Canada, Germany, U.K., France, Spain, Italy, Rest of Europe, Japan, China, India, Australia & New Zealand, South Korea, Rest of Asia Pacific, Brazil, Mexico, Rest of Latin America, GCC, South Africa, Rest of Middle East & Africa

Key Companies Profiled

9 Meters Biopharma, Inc., Alvogen, Amneal Pharmaceuticals LLC., Boehringer Ingelheim International GmbH, GSK Plc., Hanmi Pharm.Co., Ltd., Hikma Pharmaceuticals PLC, Novartis AG, Nutrinia Ltd., Pharmascience, Inc, Sanofi, Sun Pharmaceutical Industries Ltd., Johnsons & Johnsons Services Inc, Merck KGaA, Zealand Pharma A/S, OxThera, Pfizer Inc., Takeda Pharmaceutical Company Limited, VectivBio AG

Key Questions Answered in Short Bowel Syndrome Market Report

Short bowel syndrome is a condition in which the small and/or large intestine is either physically absent or does not function properly. This can lead to malnutrition and other health problems.

The global market for short bowel syndrome treatments is expected to grow at a CAGR of 14.7% from 2023 to 2030. This growth is being driven by a number of factors, including the rising incidence of short bowel syndrome, the increasing availability of innovative treatments, and the growing awareness of the condition.

The short bowel syndrome market is segmented by drug type, diagnosis, treatment, route of administration, end-users, distribution channel, and geography.

  • Drug type: The short bowel syndrome market is segmented into glucagon-like peptide-2 (GLP2), growth hormone, glutamine, anti-diarrheal, proton pump inhibitors, and others.
  • Diagnosis: The short bowel syndrome market is segmented into physical exams, fecal tests, imaging procedures, and other diagnosis.
  • Treatment: The short bowel syndrome market is segmented into nutritional therapy, medications, surgery, and transplant.
  • Route of administration: The short bowel syndrome market is segmented into oral, parenteral, and others.
  • End-users: The short bowel syndrome market is segmented into hospitals, homecare, specialty clinics, and others.
  • Distribution channel: The short bowel syndrome market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy.
  • Geography: The short bowel syndrome market is segmented into North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.

North America is expected to dominate the global short bowel syndrome market over the forecast period. This is due to the high prevalence of short bowel syndrome in the region, the increasing availability of innovative treatments, and the growing awareness of the condition.

The key challenges facing the short bowel syndrome market include the lack of qualified healthcare professionals who are able to treat patients with this condition, the high cost of treatment, and the limited availability of authorized medications in certain countries.

Single User - $4,600.00

It allows one person, the buyer, to have the sole rights and access to the purchased report. Further distribution of the product is strictly prohibited.

It allows the purchased product to be shared among 1-7 employees of your organization within the same geographical location.

It allows the purchased product to be shared among all employees of your organization irrespective of their geographical location.

Need a Custom Report?

We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Business Development

small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
Ask an Expert